Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Buy
101,360
+37,158
+58% +$1.24M ﹤0.01% 2043
2026
Q1
$1.92M Buy
64,202
+32,174
+100% +$752K ﹤0.01% 2376
2025
Q4
$728K Buy
32,028
+12,044
+60% +$325K ﹤0.01% 3640
2025
Q3
$557K Sell
19,984
-7,053
-26% -$221K ﹤0.01% 3737
2025
Q2
$990K Buy
27,037
+8,595
+47% +$401K ﹤0.01% 3345
2025
Q1
$778K Sell
18,442
-7,770
-30% -$455K ﹤0.01% 3257
2024
Q4
$1.71M Buy
26,212
+13,775
+111% +$957K ﹤0.01% 3016
2024
Q3
$766K Buy
12,437
+9,854
+381% +$596K ﹤0.01% 3527
2024
Q2
$194K Buy
+2,583
New +$241K ﹤0.01% 3594

Other funds holding IBTA

Barclays's IBTA Position: Q2 2026 in Review

Barclays increased its Ibotta (IBTA) stake by 58% in Q2 2026, buying an estimated $1.24M and bringing the position to 101,360 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Barclays first reported a position in IBTA in Q2 2024 and has held it in 9 quarters since. 146 funds tracked by Wall St. Rank hold IBTA as of Q2 2026.

  • Barclays held 101,360 shares of Ibotta worth $3.46M as of Q2 2026.
  • Barclays bought 37,158 Ibotta shares in Q2 2026, an estimated $1.24M.
  • Ibotta made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2043 holding.
  • Barclays first reported a position in Ibotta in Q2 2024 and has held it in 9 quarters since.
  • 146 funds tracked by Wall St. Rank held Ibotta as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.